Key points
- Legal cannabis employed 412,500 people in early 2026, down 2.7% from a year earlier.
- National legal retail revenue dropped to $29.1 billion, the first year-over-year decline on record.
- Legal sales capture about 30% of the total addressable market, leaving most demand and jobs in unregulated channels.
The legal U.S. cannabis industry employed 412,500 people in early 2026 – down 2.7% from 425,002 jobs reported last year.
Legal retail revenue fell to $29.1 billion – the first year-over-year decline since adult-use sales began in 2014, according to the newly released U.S. Cannabis Jobs Report 2026 from Denver-based cannabis staffing platform Vangst and Oregon-based cannabis data and research company Whitney Economics.
It’s a signal that the cannabis industry is beginning to operate like a mature consumer market – one where customers are still buying, prices are falling, margins are tightening and jobs are becoming harder to add.
“Growth is sustained as you convert consumers from the unregulated market to the regulated market,” economist Beau Whitney told MJBizDaily.
“Most have now converted as many consumers as they can, so there’s not much growth to be gleaned unless you change the way marijuana is distributed. Right now, it’s distributed in dispensaries, but that’s a failed model because you’re limiting consumer access.”
Why is the cannabis industry losing jobs?
The simplest explanation is maturity. Wholesale prices continue to fall; oversupply remains a drag in several markets; and operators are fighting to protect margins in a deflationary environment.
“In the U.S., we’re oversaturated with supply, leading to price compression,” Whitney said. “Prices are below the cost of production.”
Yet demand has not disappeared. Consumers are still filling their baskets – they’re just paying less for them.
A basket that might have cost $150 three years ago could cost closer to $97 today. Shoppers keep the savings and redirect them to gas, groceries and other household expenses, according to the report.
Operators, meanwhile, face higher costs for fuel, utilities, labor and services while the revenue attached to each transaction shrinks.
“Despite its challenges and despite the turmoil, there’s still a significant number of jobs resulting from the deployment of the cannabis industry,” Whitney said. “There’s been some softness, but that softness occurs whenever a market matures. Most of the growth comes early on.”
Where are the cannabis industry’s job losses and gains happening?
The jobs data shows a widening divide between markets that have already converted much of their legacy demand into regulated sales and states that are still building out retail access.
In mature markets, such as California, Colorado, Washington, Oregon and Michigan, the first wave of growth has largely passed.
California, with 57,500 jobs, and Michigan, with 42,500, remain the two largest cannabis employers. But both markets contracted as oversupply, price compression and new taxes pushed operators to cut costs and operate leaner.
Emerging markets tell the opposite story. Six states posted double-digit job growth.
- New York more than doubled its cannabis workforce, adding 16,160 jobs – a 129% jump – to reach 28,660 and become the nation’s third-largest cannabis employer.
- Maryland gained 3,500 jobs.
- Ohio added 2,596.
Those increases helped to offset job losses in other states.
“It may look like a geography story, but it’s really a maturity story,” Ryan Rosenfeld, chief business officer at Vangst told MJBizDaily. “California and Michigan are becoming more efficient as operators adjust to price compression and optimize staffing. Meanwhile, New York, Maryland and Ohio are still in growth mode.
“The lesson for MSOs: Invest in growth markets but apply mature-market discipline from Day 1 – hire thoughtfully, stay lean and avoid overbuilding.”
How will federal rescheduling impact cannabis jobs?
The biggest variable for 2026 and 2027 is federal policy.
If adult-use cannabis moves from Schedule 1 to Schedule 3, relief from Internal Revenue Service Code Section 280E could free up meaningful capital for operators that have been carrying heavy tax burdens. That money could go toward debt repayment, marketing expansion, lower consumer prices or all of the above, Whitney said.
But rescheduling isn’t a clean fix to the cannabis industry’s woes.
Whitney warned that a dual medical and adult-use system could create new complications.
Schedule 3 treatment could limit some retail activity to pharmacies operating under pharmacist direction, while cultivation appears to be especially exposed.
“You can’t sell Schedule 3 drugs unless it’s sold at a pharmacy,” Whitney said.
“If you have a DEA-sanctioned medical program and a state-sanctioned adult-use program, how will that work form a regulatory perspective, and how will it work from an operator and consumer perspective?”
Not every operator will be able to meet good manufacturing practice (GMP) and good agricultural practice (GAP) certification requirements, and future price declines could push more producers out of the market.
“They won’t be able to manage the cost given how much prices have collapsed,” Whitney said.
Who will buy medical marijuana?
The pricing question may be just as important.
If medical cannabis costs more than adult-use products, consumers may have little reason to switch into the medical channel.
Whitney pointed to one potential incentive that could change that math: insurance reimbursement, which could make medical participation more attractive.
The scale of opportunity remains large. Whitney estimates the industry could support 1.6 million workers under full descheduling.
Subscribe to the MJBiz Factbook
Exclusive industry data and analysis to help you make informed business decisions and avoid costly missteps. All the facts, none of the hype.
What you will get:
- Monthly and quarterly updates, with new data & insights
- Financial forecasts + capital investment trends
- State-by-state guide to regulations, taxes & market opportunities
- Annual survey of cannabis businesses
- Consumer insights
- And more!
Today, legal sales capture only about 30% of the total addressable cannabis market, leaving most demand – and jobs – in unregulated channels.
“They still hire people – they just pay in cash that’s untaxed,” he said. “The key is to convert that demand over into the legal regulated space, rather than keep it on the illicit side.”
Margaret Jackson can be reached at margaret.jackson@mjbizdaily.com.
